American International Group, Inc. Codiak Bio Sciences, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.24 - $6.96 $17,691 - $54,970	-7,898 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.3 - $12.95 $2,386 - $7,187	-555 Reduced 6.57%	7,898 $50,000
Q4 2021 Feb 11, 2022	SELL	$10.0 - $16.78 $2,540 - $4,262	-254 Reduced 2.92%	8,453 $94,000
Q3 2021 Nov 12, 2021	SELL	$15.58 - $22.88 $1,433 - $2,104	-92 Reduced 1.05%	8,707 $142,000
Q2 2021 Aug 13, 2021	BUY	$11.72 - $26.81 $59,186 - $135,390	5,050 Added 134.7%	8,799 $163,000
Q1 2021 May 07, 2021	BUY	$13.49 - $31.53 $7,028 - $16,427	521 Added 16.14%	3,749 $57,000
Q4 2020 Feb 12, 2021	BUY	$7.9 - $32.3 $25,501 - $104,264	3,228 New	3,228 $104,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.